U.S. flag An official website of the United States government
  1. Home
  2. Vaccines, Blood & Biologics
  3. Cellular & Gene Therapy Products
  4. KYMRIAH (tisagenlecleucel)
  1. Cellular & Gene Therapy Products

KYMRIAH (tisagenlecleucel)

STN:  125646
Proper Name:  tisagenlecleucel
Tradename: KYMRIAH
Manufacturer: Novartis Pharmaceuticals Corporation

  • KYMRIAH is a CD19-directed genetically modified autologous T cell immunotherapy indicated for the treatment of adult patients with relapsed or refractory follicular lymphoma after two or more lines of therapy

Product Information

Supporting Documents

Related Information

Back to Top